Increasing evidence in scientific journals declares that stem cell can be used in human medicine for therapeutic purposes. We reviewed the lated literature on clinical trials conducted with stem cells. The main information was offered by http://www.ClinicalTrials.gov . These clinical trials cover almost all human diseases, from hematologic diseases to non-hematologic diseases including Interventional trials and observational trials. In conclusion, at present, the clinical trials with stem cells have been extending to almost all human diseases. Optimal medicinal effect reported in some non-hematologic diseases is pushing the advance of stem cells therapy
Reya, T., Morrison, S.J., Clarke, M.F. and Weissman, I.L. (2001) Stem cells, cancer, and cancer stem cells. Nature, 414, 105-111. doi:10.1038/35102167
Cancer statistics (Epub ahead of print) (2012).
M.D. Anderson Cancer Center (2010) Decitabine and peripheral stem cell transplantation in treating patients who have relapsed following bone marrow transplantation for leukemia, myelodysplastic syndrome, or chronic myelogenous leukemia. http://clinicaltrials.gov/ct2/show/NCT00002832
St. Jude Children’s Research Hospital (2009) Haploidentical stem cell transplant for patients with sickle cell disease and prior stroke or abnormal transcranial ultrasound. http://clinicaltrials.gov/ct2/show/NCT00152113
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium (2012) Donor peripheral blood stem cell transplant in treating patients with hematologic malignancies. http://clinicaltrials.gov/ct2/show/NCT01028716
M.D. Anderson Cancer Center (2011) Non-myeloablative allogeneic stem cell transplantation. http://clinicaltrials.gov/ct2/show/NCT00525876
Efebera, Y.A., Qureshi, S.R. and Khouri, I.F. (2010) Reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed multiple myeloma. Biology of Blood and Marrow Transplantation, 16, 1122-1129. doi:10.1016/j.bbmt.2010.02.015
Fred Hutchinson Cancer Research Center (2011) Busulfan and etoposide followed by peripheral blood stem cell transplant and low-dose aldesleukin in treating patients with acute myeloid leukemia. http://clinicaltrials.gov/ct2/show/NCT00003875
Emory University (2011) Combination high dose melphalan and autologous peripheral blood stem cell (PBSC) transplant with bortezomib for multiple myeloma: A dose and schedule finding study. http://clinicaltrials.gov/ct2/show/NCT00793650
University of Bologna (2006) Autologous transplantation for multiple myeloma. http://clinicaltrials.gov/ct2/show/NCT00378222
Fudan University (2012) IGEV followed by autologous transplantation for refractory or relapsed hodgkin lymphoma. http://clinicaltrials.gov/ct2/show/NCT01333605
American Heart Association (2008) http://www.americanheart.org
National Heart Institute, Mexico (2008) Intracoronary autologous stem cell transplantation in ST elevation myocardial infarction: Tracia study. http://clinicaltrials.gov/ct2/show/NCT00725738
Meshalkin Research Institute of Pathology of Circulation (2012) “Estimation study” for endocardial mesenchymal stem cells implantation in patients after acute myocardial infarction. http://clinicaltrials.gov/ct2/show/NCT01394432
Barts & The London NHS Trust (2011) Bone marrow derived adult stem cells for acute anterior myocardial infarction (REGEN-AMI). http://clinicaltrials.gov/ct2/show/NCT00765453
University of Zurich (2008) Swiss multicenter intracoronary stem cells study in acute myocardial infarction (SWISS-AMI). http://clinicaltrials.gov/ct2/show/NCT00355186
Kyoto Prefectural University of Medicine (2011) Autologous human cardiac-derived stem cell to treat ischemic cardiomyopathy (ALCADIA). http://clinicaltrials.gov/ct2/show/NCT00981006
Shanghai Jiao Tong University, School of Medicine (2012) Autologous hematopoietic stem cell transplantation for early onset type 1 diabetes. http://clinicaltrials.gov/ct2/show/NCT00807651
Zhang., X.F., Ye, L. and Hu, J. (2012) Acute response of peripheral blood cell to autologous hematopoietic stem cell transplantation in type 1diabetic patient. PLOS One, 7, e31887. doi:10.1371/journal.pone.0031887
Boston Medical Center (2012) Bortezomib and dexamethasone followed by high-dose melphalan and stem cell transplantation for primary (AL) amyloidosis. http://clinicaltrials.gov/ct2/show/NCT01083316
Stanford University (2010) Autologous stem cell rescue for primary amyloidosis. http://clinicaltrials.gov/ct2/show/NCT00186407
Adistem Ltd. (2008) Safety and efficacy of autologous adipose-derived stem cell transplantation in type 2 diabetics. http://clinicaltrials.gov/ct2/show/NCT00703612
Cellonis Biotechnology Co. Ltd. (2010) Stem cell therapy for type 2 diabetes mellitus. http://clinicaltrials.gov/ct2/show/NCT01142050
Postgraduate Institute of Medical Education and Research (2008) Efficacy of autologous bone marrow derived stem cell transplantation in patients with type 2 diabetes mellitus (SCT). http://clinicaltrials.gov/ct2/show/NCT00644241
Marmont, A.M., van Lint, M.T., Gualandi, F. and Bacigalupo, A. (1997) Autologous marrow mstem cell transplantation for systemic lupus erythematosus of long duration. Lupus, 6, 545-548. doi:10.1177/096120339700600613
Fairview University Medical Center (2005) Autologous peripheral blood stem cell transplantation in patients with life threatening autoimmune diseases. http://clinicaltrials.gov/ct2/show/NCT00006055
National Cancer Institute (NCI) (2012) Lymphocyte depletion and stem cell transplantation to treat severe systemic lupus erythematosus. http://clinicaltrials.gov/ct2/show/NCT00076752
Charite University (2011) Autologous stem cell transplantation for refractory systemic lupus erythematosus (ASSIST). http://clinicaltrials.gov/ct2/show/NCT00750971
Burt, R. (2012) Allogeneic stem cell transplantation in systemic lupus erythematosus. http://clinicaltrials.gov/ct2/show/NCT00278590
National Heart, Lung, and Blood Institute (NHLBI) (2009) Allogeneic blood stem cell transplantation for patients with life-threatening systemic lupus erythematosus. http://clinicaltrials.gov/ct2/show/NCT00325741
St. Jude Children’s Research Hospital (2009) Transplantation of hematopoietic cells in children with severe combined immunodeficiency syndrome. http://clinicaltrials.gov/ct2/show/NCT00152100
National Human Genome Research Institute (NHGRI) (2012) Gene transfer therapy for severe combined immunodeficieny disease (SCID) due to adenosine deaminase (ADA) deficiency. http://clinicaltrials.gov/show/NCT00018018
Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E. and Forman, D. (2011) Global cancer statistics. A Cancer Journal for Clinicians, 61, 69-90.
H. Lee (2009) Combination chemotherapy followed by peripheral stem cell transplantation in treating women with metastatic breast cancer. http://clinicaltrials.gov/ct2/show/NCT00006032
Robert H. and Lurie Cancer Center (2009) Combination chemotherapy and peripheral stem cell transplantation in treating women with metastatic breast cancer. http://clinicaltrials.gov/ct2/show/NCT00004906
Northwestern University (2011) Chemotherapy, filgrastim, and stem cell transplantation with radiation therapy in treating patients with stage III or stage IV breast cancer. http://clinicaltrials.gov/show/NCT00004172